{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52945"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52945","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"PURSUING QUANTITATIVE MEASUREMENT OF BRAIN PROTEOFORMS BY MASS SPECTROMETRY-BASED TOP-DOWN PROTEOMICS","abstract":"Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","abstract_html":"Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","abstract_has_math":false,"creators":["Falamarzi Askarani, Mehrdad"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Sun, Dr. Liangliang","Swain, Dr. Greg","Blanchrad, Dr. Garry","Cibelli, Dr. Jose"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T18:59:34Z","subjects":["Analytical chemistry"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52945","local:FalamarziAskarani_grad.msu_0128D_21955"],"render_values":[{"text":"etd:52945","href":null,"code":true},{"text":"local:FalamarziAskarani_grad.msu_0128D_21955","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/bndk-md10","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/bndk-md10","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52945","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Sun, Dr. Liangliang","Swain, Dr. Greg","Blanchrad, Dr. Garry","Cibelli, Dr. Jose"]},{"key":"dc:creator","label":"Author","values":["Falamarzi Askarani, Mehrdad"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Analytical chemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52945","local:FalamarziAskarani_grad.msu_0128D_21955","https://doi.org/doi:10.25335/bndk-md10"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","ABSTRACTPURSUING QUANTITATIVE MEASUREMENT OF BRAIN PROTEOFORMS BY MASS SPECTROMETRY-BASED TOP-DOWN PROTEOMICS By Mehrdad Falamarzi AskaraniThe brain is one of the most complex biological systems, with molecular heterogeneity arising not only from gene expression but also from extensive proteoform diversity generated through alternative splicing, sequence variation, and post-translational modifications. While bottom-up proteomics has enabled large-scale protein identification, it remains limited in its ability to resolve highly similar protein isoforms and fully characterize post-translational modifications in their native context. Top-down proteomics (TDP), which analyzes intact proteins, overcomes these limitations by enabling confident identification and quantification of proteoforms and providing a more accurate view of molecular mechanisms underlying brain function and disease.This thesis presents a comprehensive investigation of brain proteoforms using mass spectrometry–based TDP, with a particular emphasis on capillary zone electrophoresis–tandem mass spectrometry (CZE-MS/MS) as a high-resolution and mass-efficient analytical platform. By leveraging the advantages of CZE-MS/MS—including minimal sample loss, compatibility with limited biological material, and high separation efficiency for intact proteins—this work advances proteoform-level understanding of neurodegenerative disease, brain aging, sexual dimorphism, regional specialization, and inter-organ molecular crosstalk. In Chapter 2, one of the first quantitative TDP studies of human Alzheimer’s disease (AD) is presented. Postmortem cortical tissues from AD patients and healthy controls were analyzed using size-exclusion chromatography coupled with CZE-MS/MS (SEC-CZE-MS/MS). A total of 3,191 unique proteoforms were identified, revealing profound remodeling of the proteoform landscape in AD. More than 2,200 proteoforms were uniquely detected in either AD or control samples, and 157 proteoforms exhibited statistically significant abundance differences. Functional enrichment analyses implicated pathways central to AD pathology, including telomere organization, amyloid fibril formation, microtubule cytoskeleton organization, synaptic potentiation, and axonogenesis. These results highlight the value of proteoform-resolved analysis for uncovering molecular mechanisms and identifying candidate biomarkers in neurodegenerative disease. Chapter 3 investigates age- and sex-dependent proteoform dynamics in the zebrafish (Danio rerio) brain. Using CZE-MS/MS-based TDP, male and female brains were analyzed at 6, 16, and 24 months of age. Significant age- and sex-specific proteoform changes were observed in pathways related to neurofilament assembly, synaptic function, dopaminergic neuron differentiation, and energy metabolism. Notably, a truncated proteoform of AP2B1 was detected exclusively in 24-month-old female brains, suggesting sex-specific molecular mechanisms in brain aging. In Chapter 4, spatial proteoform heterogeneity within the brain was examined through region-specific analysis of four zebrafish brain regions: telencephalon, habenula–optic tectum, cerebellum, and medulla. Label-free quantitative TDP identified 1,050 proteoforms from 336 proteins, with only 5.1% shared across all regions, demonstrating pronounced regional specialization at the proteoform level. Proteoforms derived from the same genes often displayed opposing regional expression patterns, underscoring functional diversity that cannot be inferred from gene- or protein-level measurements. Comparisons with bottom-up proteomics further validated the unique biological insights gained through TDP. Chapter 5 extends proteoform profiling beyond the brain to a multi-organ analysis of zebrafish brain, heart, and liver. Across these tissues, 14,094 non-redundant proteoforms were identified at a 1% false discovery rate, revealing strong tissue- and sex-specific expression patterns. Functional enrichment analyses highlighted both tissue-specific processes and shared pathways, including glycolysis and estrogen signaling, suggesting inter-organ molecular connectivity. Distinct phosphorylation patterns of Thymosin beta proteoforms across tissues further emphasized tissue-specific functional roles. Collectively, this thesis demonstrates that CZE-MS/MS-based TDP provides unparalleled resolution for characterizing proteoform diversity in the brain and beyond. The resulting proteoform atlases, biological insights, and methodological advances establish a foundation for future proteoform-based studies of brain function, aging, and neurological disease, and support the development of proteoform-resolved diagnostics and therapeutic strategies.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (282 p.) : ill."]},{"key":"dc:title","label":"Title","values":["PURSUING QUANTITATIVE MEASUREMENT OF BRAIN PROTEOFORMS BY MASS SPECTROMETRY-BASED TOP-DOWN PROTEOMICS"]}]}],"canonical_facts":{"dc:contributor":["Sun, Dr. Liangliang","Swain, Dr. Greg","Blanchrad, Dr. Garry","Cibelli, Dr. Jose"],"dc:creator":["Falamarzi Askarani, Mehrdad"],"dc:date":["2026"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","ABSTRACTPURSUING QUANTITATIVE MEASUREMENT OF BRAIN PROTEOFORMS BY MASS SPECTROMETRY-BASED TOP-DOWN PROTEOMICS By Mehrdad Falamarzi AskaraniThe brain is one of the most complex biological systems, with molecular heterogeneity arising not only from gene expression but also from extensive proteoform diversity generated through alternative splicing, sequence variation, and post-translational modifications. While bottom-up proteomics has enabled large-scale protein identification, it remains limited in its ability to resolve highly similar protein isoforms and fully characterize post-translational modifications in their native context. Top-down proteomics (TDP), which analyzes intact proteins, overcomes these limitations by enabling confident identification and quantification of proteoforms and providing a more accurate view of molecular mechanisms underlying brain function and disease.This thesis presents a comprehensive investigation of brain proteoforms using mass spectrometry–based TDP, with a particular emphasis on capillary zone electrophoresis–tandem mass spectrometry (CZE-MS/MS) as a high-resolution and mass-efficient analytical platform. By leveraging the advantages of CZE-MS/MS—including minimal sample loss, compatibility with limited biological material, and high separation efficiency for intact proteins—this work advances proteoform-level understanding of neurodegenerative disease, brain aging, sexual dimorphism, regional specialization, and inter-organ molecular crosstalk. In Chapter 2, one of the first quantitative TDP studies of human Alzheimer’s disease (AD) is presented. Postmortem cortical tissues from AD patients and healthy controls were analyzed using size-exclusion chromatography coupled with CZE-MS/MS (SEC-CZE-MS/MS). A total of 3,191 unique proteoforms were identified, revealing profound remodeling of the proteoform landscape in AD. More than 2,200 proteoforms were uniquely detected in either AD or control samples, and 157 proteoforms exhibited statistically significant abundance differences. Functional enrichment analyses implicated pathways central to AD pathology, including telomere organization, amyloid fibril formation, microtubule cytoskeleton organization, synaptic potentiation, and axonogenesis. These results highlight the value of proteoform-resolved analysis for uncovering molecular mechanisms and identifying candidate biomarkers in neurodegenerative disease. Chapter 3 investigates age- and sex-dependent proteoform dynamics in the zebrafish (Danio rerio) brain. Using CZE-MS/MS-based TDP, male and female brains were analyzed at 6, 16, and 24 months of age. Significant age- and sex-specific proteoform changes were observed in pathways related to neurofilament assembly, synaptic function, dopaminergic neuron differentiation, and energy metabolism. Notably, a truncated proteoform of AP2B1 was detected exclusively in 24-month-old female brains, suggesting sex-specific molecular mechanisms in brain aging. In Chapter 4, spatial proteoform heterogeneity within the brain was examined through region-specific analysis of four zebrafish brain regions: telencephalon, habenula–optic tectum, cerebellum, and medulla. Label-free quantitative TDP identified 1,050 proteoforms from 336 proteins, with only 5.1% shared across all regions, demonstrating pronounced regional specialization at the proteoform level. Proteoforms derived from the same genes often displayed opposing regional expression patterns, underscoring functional diversity that cannot be inferred from gene- or protein-level measurements. Comparisons with bottom-up proteomics further validated the unique biological insights gained through TDP. Chapter 5 extends proteoform profiling beyond the brain to a multi-organ analysis of zebrafish brain, heart, and liver. Across these tissues, 14,094 non-redundant proteoforms were identified at a 1% false discovery rate, revealing strong tissue- and sex-specific expression patterns. Functional enrichment analyses highlighted both tissue-specific processes and shared pathways, including glycolysis and estrogen signaling, suggesting inter-organ molecular connectivity. Distinct phosphorylation patterns of Thymosin beta proteoforms across tissues further emphasized tissue-specific functional roles. Collectively, this thesis demonstrates that CZE-MS/MS-based TDP provides unparalleled resolution for characterizing proteoform diversity in the brain and beyond. The resulting proteoform atlases, biological insights, and methodological advances establish a foundation for future proteoform-based studies of brain function, aging, and neurological disease, and support the development of proteoform-resolved diagnostics and therapeutic strategies.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (282 p.) : ill."],"dc:identifier":["etd:52945","local:FalamarziAskarani_grad.msu_0128D_21955","https://doi.org/doi:10.25335/bndk-md10"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Analytical chemistry"],"dc:title":["PURSUING QUANTITATIVE MEASUREMENT OF BRAIN PROTEOFORMS BY MASS SPECTROMETRY-BASED TOP-DOWN PROTEOMICS"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:34Z"}